Today: 23 January 2026
Subscribe
Browse Category

NYSE:SSL News 18 January 2026 - 22 January 2026

Sasol (SSL) stock jumps after fuel-sales outlook lifted, but Mozambique gas warning hangs over

Sasol (SSL) stock jumps after fuel-sales outlook lifted, but Mozambique gas warning hangs over

NEW YORK, January 22, 2026, 15:03 (EST) — Regular session Sasol Ltd’s U.S.-listed shares surged roughly 13% to $7.13 Thursday afternoon following the South African energy and chemicals company’s upgrade to its fuel sales volume forecast for fiscal 2026. Shares fluctuated between $6.45 and $7.335 during the session. Sasol now forecasts fuel sales volumes for FY26 to climb 5% to…
22 January 2026
····
Sasol share price tumbles after JPMorgan downgrade — what could move SOL and SSL next week

Sasol share price tumbles after JPMorgan downgrade — what could move SOL and SSL next week

Johannesburg, Jan 18, 2026, 16:07 SAST — Market closed Sasol Limited’s shares on the Johannesburg Stock Exchange fell 11.8% Friday, closing at 101.91 rand. Its ADRs in New York dropped 11.75%, finishing at $6.31. The stock remains under close scrutiny as trading picks up again. (StockAnalysis) Timing is crucial. Sasol plans to release its Q2 FY26 performance figures on Jan.…
18 January 2026
·····

Stock Market Today

  • MiMedx Group's Updated Price Target Drives New Investor Focus
    January 22, 2026, 6:46 PM EST. MiMedx Group (MDXG) has seen a shift in its analyst price target, reflecting updated views on its business execution, balance sheet, and market risks. Price targets serve as analysts' estimates of fair value based on current data but should be one of several factors investors consider. The change highlights evolving sentiment about the company's prospects, though it does not guarantee stock moves. Monitoring future price target revisions can reveal trends in analyst confidence. Investors are encouraged to explore Simply Wall St's community Narratives for detailed perspectives linking company forecasts to fair value estimates, aiding informed decisions amid shifting expectations for MiMedx Group.
Go toTop